This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials.
JCO clinical cancer informatics · 2025
Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma.
BMJ open · 2025
Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data
Immunotherapy · 2025
Latest funding
- $742,052
A Randomized Phase III Multicentre Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula
CIHR · 2024 · Nominated PI
- $1,690,827
A Randomized Phase III Trial of Preoperative Chemoradiotherapy vs Preoperative Chemotherapy for Resectable Gastric Cancer
CIHR · 2011 · Nominated PI
5 publications.
Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials.
Nicholls DL, Xu MC, Zhan L, Sharma D, Hueniken K, Chiasson K, Wahba M, Brown MC, Grant B, Shapiro J, Karapetis CS, Simes J, Jonker D, Tu D, O'Callaghan C, Chen E, Liu G
Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma.
McParland K, Koh ES, Kong B, Sim HW, Thavaneswaran S, Yip S, Barnes EH, Ballinger ML, Thomas DM, De Abreu Lourenco R, Simes J, Sebastian L, Wheeler PJ, Spyridopoulos D, Hawkins C, Pitz M, O'Callaghan C, Gan HK
Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data
Coschi CH, Ding K, Tong J, Tu D, O’Callaghan C, Leighl NB, Vera-Badillo F, Juergens RA, Hao D, Seymour L
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials
Coschi CH, Ding K, Tu D, O’Callaghan C, Leighl NB, Vera-Badillo F, Juergens RA, Hao D, Seymour L, Renouf DJ
Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial
X L, Titmuss E, Loree JM, Jonker DJ, Kennecke HF, Berry S, Couture F, Ahmad CE, Goffin JR, Kavan P
A Randomized Phase III Multicentre Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula
Principal investigators: O'Callaghan, Christopher J; Karanicolas, Paul J
Keywords: Distal Pancreatectomy; Lanreotide; Pancreatic Cancer; Phase Iii; Postoperative Pancreatic Fistula (Popf); Quality Of Life; Rct; Somastatin Analogues (Ssas); Surgery
A Randomized Phase III Trial of Preoperative Chemoradiotherapy vs Preoperative Chemotherapy for Resectable Gastric Cancer
Principal investigators: O'Callaghan, Christopher J; Wong, Rebecca K
Keywords: Chemotherapy; Controlled Clinical Trial; Gastric Cancer; Radiotherapy; Surgery
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Oncology
- Department of Laboratory Medicine and Pathobiology
- Department of Medicine
- Biostatistics Division
- Epidemiology Division
- Internal Medicine
- Other
Co-authors at Queen's University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Courtney Heather Coschi
Oncology
2 shared papers, latest 2025
Rosalyn Juergens
Oncology
2 shared papers, latest 2025
Lesley Seymour
Faculty
2 shared papers, latest 2025
Divya Sharma
Biostatistics Division
1 shared papers, latest 2025
Derek Jonker
Department of Medicine
1 shared papers, latest 2025
Marshall Pitz
Internal Medicine
1 shared papers, latest 2025
Geoffrey Liu
Epidemiology Division
1 shared papers, latest 2025
John Goffin
Oncology
1 shared papers, latest 2024
Cynthia Hawkins
Department of Laboratory Medicine and Pathobiology
1 shared papers, latest 2025
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.